These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37474470)

  • 1. Liver macrophages show an immunotolerance phenotype in nonalcoholic fatty liver combined with
    Guo L; Liu Y; Chen Y; Xu J; Liu Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Aug; 41(4):385-394. PubMed ID: 37474470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage specific restoration of the Nrf2 gene in whole-body knockout mice ameliorates steatohepatitis induced by lipopolysaccharide from Porphyromonas gingivalis through enhanced hepatic clearance.
    Chihara K; Okada K; Uchida F; Miura I; Komine S; Warabi E; Takayama T; Suzuki H; Matsuzaka T; Ishibashi-Kanno N; Yamagata K; Yanagawa T; Bukawa H; Shoda J
    PLoS One; 2023; 18(10):e0291880. PubMed ID: 37862331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway.
    Ahn JS; Yang JW; Oh SJ; Shin YY; Kang MJ; Park HR; Seo Y; Kim HS
    BMB Rep; 2021 Jun; 54(6):323-328. PubMed ID: 34078528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.
    Tao L; Yi Y; Chen Y; Zhang H; Orning P; Lien E; Jie J; Zhang W; Xu Q; Li Y; Ding Z; Wu C; Ding Q; Wang J; Zhang J; Weng D
    Cell Death Differ; 2021 Apr; 28(4):1418-1433. PubMed ID: 33208891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages.
    McGettigan B; McMahan R; Orlicky D; Burchill M; Danhorn T; Francis P; Cheng LL; Golden-Mason L; Jakubzick CV; Rosen HR
    Hepatology; 2019 Jul; 70(1):67-83. PubMed ID: 30516830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 8. Vsig4
    Li HY; Fu SW; Wu JC; Li ZH; Xu MY
    Inflamm Res; 2023 Apr; 72(4):669-682. PubMed ID: 36745210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways.
    Ding LY; Liang LZ; Zhao YX; Yang YN; Liu F; Ding QR; Luo LJ
    Oral Dis; 2019 Oct; 25(7):1789-1797. PubMed ID: 31283861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
    Nakahara T; Hyogo H; Ono A; Nagaoki Y; Kawaoka T; Miki D; Tsuge M; Hiraga N; Hayes CN; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Abe-Chayama H; Furusho H; Shintani T; Kurihara H; Miyauchi M; Takata T; Arihiro K; Chayama K
    J Gastroenterol; 2018 Feb; 53(2):269-280. PubMed ID: 28741270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH.
    Nagasaki A; Sakamoto S; Arai T; Kato M; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
    J Clin Periodontol; 2021 Oct; 48(10):1367-1378. PubMed ID: 34250613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
    Cheng Y; Chen T; Ping J; Chen J
    Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
    Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
    Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.
    Furusho H; Miyauchi M; Hyogo H; Inubushi T; Ao M; Ouhara K; Hisatune J; Kurihara H; Sugai M; Hayes CN; Nakahara T; Aikata H; Takahashi S; Chayama K; Takata T
    J Gastroenterol; 2013 Nov; 48(11):1259-70. PubMed ID: 23307045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient chaperone-mediated autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85.
    Zhang M; Tian SY; Ma SY; Zhou X; Zheng XH; Li B; Guo GY; Yu JH; Su R; Yang FF; Hu YN; Ma G; Yang H; Zheng LH; Guo CC; Shang YL; Wang JB; Han Y
    Liver Int; 2023 May; 43(5):1021-1034. PubMed ID: 36912786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
    Yoneda M; Naka S; Nakano K; Wada K; Endo H; Mawatari H; Imajo K; Nomura R; Hokamura K; Ono M; Murata S; Tohnai I; Sumida Y; Shima T; Kuboniwa M; Umemura K; Kamisaki Y; Amano A; Okanoue T; Ooshima T; Nakajima A
    BMC Gastroenterol; 2012 Feb; 12():16. PubMed ID: 22340817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osr1 Regulates Macrophage-mediated Liver Inflammation in Nonalcoholic Fatty Liver Disease Progression.
    Liu L; Zhou Y; Liu Z; Li J; Hu L; He L; Gao G; Kidd B; Walsh A; Jiang R; Wu C; Zhang K; Xie L
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1117-1133. PubMed ID: 36581078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
    Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
    Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.